GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › BDX growth analysis
Growth stock analysis · updated 2026-07-27

Becton, Dickinson and Co. (BDX) growth stock analysis

Is Becton, Dickinson and Co. a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
19
Growth score
33
RS rating
#3,830
Rank
0/6
Traits passed
19/99
Growth score · 3830th of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about BDX

As of the 2026-07-27 close, BDX scores 19 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 3830th of 4,897 rated US stocks, the top 78% of the market.

Its strongest trait is I (institutional sponsorship) at 54, and its weakest is N (new highs & catalysts) at 2. BDX clears 0 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, BDX carries a lagging Relative Strength rating of 33, meaning it has outperformed about 33% of the market over the past year.

Underneath the score: quarterly earnings down 204% year over year, sales up 5%, trading 24% below its 52-week high.

BDX growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
35
A
Annual earnings growth
multi-year earnings trend
34
N
New highs & catalysts
proximity to new 52-week highs
2
S
Supply & demand
volume behind the move vs. share supply
20
L
Leader or laggard
Relative Strength within its group
31
I
Institutional sponsorship
fund accumulation and 13F ownership
54

Is BDX a growth stock?

Not right now by CANSLIM

On today’s data BDX does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than BDX

The stocks ranking above BDX today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 BDX price history & buy range

Where BDX sits in its base, its 52-week path, and the trait trend over the past year.

Open the full BDX profile →

See where BDX ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

BDX as a growth stock, frequently asked

Is BDX a good growth stock?

Not right now by CANSLIM. On today’s data BDX does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is BDX's growth score?

Becton, Dickinson and Co. (BDX) scores 19 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 3830th of 4,897 rated US stocks.

Does BDX have strong earnings growth?

BDX's most recent quarterly earnings were down about 204% year over year, with sales up 5%.

How strong is BDX's price performance?

BDX has a Relative Strength rating of 33, meaning it has outperformed roughly 33% of the US market over the trailing year.

Where can I see BDX's full analysis?

Create a free Growth Stock Analyzer account to see where BDX ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Surgical & Medical Instruments & Apparatus